Cancer Therapy
New Taxol prodrugs designed for cancer chemotherapy
Published in Cancer Weekly, September 5th, 2006
According to recent research published in the journal Bioorganic & Medicinal Chemistry, "Two new glucuronide paclitaxel prodrugs have been synthesized."
"Linked to the 2'-OH of the drug by a carbonate function, they include a self-immolative spacer bearing an arylnitro or arylamino group between the drug and the glucuronic acid residue. Both prodrugs were well detoxified and easily cleaved in the presence of P-D-glucuronidase with fast removal of the spacer, releasing paclitaxel," explained A. Elalaoui and colleagues, Institut Curie.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-05)
More Articles from Cancer Weekly
- Childhood Cancer
Adult survivors of childhood cancer may be at risk of unemployment - Head & Neck Cancer
Head and neck squamous cell carcinoma risk reduced in smokers and drinkers by dietary antioxidants - Mental Health
Adults with serious mental illness have elevated cancer incidence - Prostate Cancer
Prostate cancer patients assessed for anxiety by Memorial Anxiety Scale for Prostate Cancer - Acid Reflux
Researchers discover how acid reflux leads to esophageal cancer - Acute Myeloid Leukemia
Dacogen (decitabine) for Injection receives U.S. orphan drug designation for patients with AML - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
